Evidence map›Paper›PMID 24012538›Full record

ArticleJournal of molecular and cellular cardiology2013

Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations.

Balazs Horvath, Tamas Banyasz, Zhong Jian, Bence Hegyi, Kornel Kistamas, Peter P Nanasi, Leighton T Izu, Ye Chen-Izu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. MOG1medRxiv : the preprint server for health sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Conductance Changes of NaPharmaceuticals (Basel, Switzerland) · 2023
    Article
  10. Antiarrhythmic and Inotropic Effects of Selective NaInternational journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Late NaPharmaceuticals (Basel, Switzerland) · 2021
    Article
  18. Cardiomyocyte NaBasic research in cardiology · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Balazs HorvathDepartment of Pharmacology, University of California, Davis, USA; Department of Physiology, University of Debrecen, MHSC, Debrecen, Hungary.
Tamas Banyasz
Zhong Jian
Bence Hegyi
Kornel Kistamas
Peter P Nanasi
Leighton T Izu
Ye Chen-Izu
University of Debrecen · HUUniversity of California, Davis · US

Funding

Sarcomere Length Shortening and the Destabilization of the Ca2+ Control System inR01HL090880 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IZU, LEIGHTON T. · 2009 to 2012
$1.5M
CaMKII Inhibition as a New Therapeutic Strategy for Treating Hypertension-inducedR03AG031944 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEN-IZU, YE · 2009 to 2010
$125k
NHLBI NIH HHS R01 HL090880NHLBI NIH HHS R01 HL90880NIA NIH HHS AG031944NIA NIH HHS R03 AG031944
6 · The paper itself

Abstract

The objective of this work is to examine the contribution of late Na(+) current (INa,L) to the cardiac action potential (AP) and arrhythmogenic activities. In spite of the rapidly growing interest toward this current, there is no publication available on experimental recording of the dynamic INa,L current as it flows during AP with Ca(2+) cycling. Also unknown is how the current profile changes when the Ca(2+)-calmodulin dependent protein kinase II (CaMKII) signaling is altered, and how the current contributes to the development of arrhythmias. In this study we use an innovative AP-clamp Sequential Dissection technique to directly record the INa,L current during the AP with Ca(2+) cycling in the guinea pig ventricular myocytes. First, we found that the magnitude of INa,L measured under AP-clamp is substantially larger than earlier studies indicated. CaMKII inhibition using KN-93 significantly reduced the current. Second, we recorded INa,L together with IKs, IKr, and IK1 in the same cell to understand how these currents counterbalance to shape the AP morphology. We found that the amplitude and the total charge carried by INa,L exceed that of IKs. Third, facilitation of INa,L by Anemone toxin II prolonged APD and induced Ca(2+) oscillations that led to early and delayed afterdepolarizations and triggered APs; these arrhythmogenic activities were eliminated by buffering Ca(2+) with BAPTA. In conclusion, INa,L contributes a significantly large inward current that prolongs APD and unbalances the Ca(2+) homeostasis to cause arrhythmogenic APs.

Indexed as

Action PotentialsAnimalsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cardiotonic AgentsCnidarian VenomsGuinea PigsHeart VentriclesMaleMyocytes, CardiacSarcoplasmic ReticulumSodiumSodium-Calcium ExchangerSodium ChannelsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Cardiotonic AgentsCnidarian VenomsSodiumSodium-Calcium ExchangerSodium Channelstoxin II (Anemonia sulcata)Action potentialCalciumCardiacLate Na(+) currentMyocyteNa(+) channel

Identifiers

PMID24012538
PMCPMC3856763
OpenAlexW2030695893

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.